proline has been researched along with Pantothenate Kinase-Associated Neurodegeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pauls, KA; Timmermann, L | 1 |
| Chae, JH; Cho, A; Hwang, H; Hwang, YS; Jeon, BS; Ki, CS; Kim, KJ; Kim, YE; Lim, BC; Lim, YH; Paek, SH; Yun, JY | 1 |
2 other study(ies) available for proline and Pantothenate Kinase-Associated Neurodegeneration
| Article | Year |
|---|---|
Deep brain stimulation in Pantothenate Kinase Associated Neurodegeneration: challenges for the future.
Topics: Arginine; Deep Brain Stimulation; Female; Humans; Male; Mutation; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Proline | 2012 |
Pantothenate kinase-associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation.
Topics: Adolescent; Adult; Aged; Arginine; Child; Deep Brain Stimulation; Disability Evaluation; DNA Mutational Analysis; Female; Globus Pallidus; Humans; Longitudinal Studies; Male; Middle Aged; Mutation; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Proline; Republic of Korea; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2012 |